1. Osteoarthritis is more common in men than women.

2. Which pharmacologic treatment is strongly recommended by ACR and OARSI for an otherwise healthy patient with osteoarthritis of the knee?

3. Which of the following receptors does NGF bind to?

4. What are some of the adverse events reported by patients who participated in the tanezumab and fasinumab studies?

« Return to Activity